T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10

Nature Immunology

Volumn 14, Issue 7, 2013, Pages 741-748

  Bandala Sanchez, Esther ^a,b   Zhang, Yuxia ^a,b   Reinwald, Simone ^a,b   Dromey, James A ^a,d   Lee, Bo Han ^a,b   Qian, Junyan ^a,b,e   Böhmer, Ralph M ^a,b   Harrison, Leonard C ^a,b,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD52 ANTIGEN; GLUTAMATE DECARBOXYLASE 65; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIGLEC 10 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HOMEOSTASIS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED NOD; MICE, SCID; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84879365270     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2610     Document Type: Article

References (46)

1. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003). (Pubitemid 36222930)
2. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003). (Pubitemid 36432314)
3. Shevach, E.M. From vanilla to 28 favors: multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006). (Pubitemid 44224153)
4. Corthay, A. How do regulatory T cells work? Scand. J. Immunol. 70, 326-336 (2009).
5. + T regulatory cells in human autoimmunity: more than a numbers game. J. Immunol. 187, 2061-2066 (2011).
6. Gavin, M.A. et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103, 6659-6664 (2006).
7. + T cells. Eur. J. Immunol. 37, 129-138 (2007). (Pubitemid 46128793)
8. Roncarolo, M.G. & Gregori, S. Is FOXP3 a bona fde marker for human regulatory T cells? Eur. J. Immunol. 38, 925-927 (2008).
9. + T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911 (2009).
10. + T reg cells. J. Exp. Med. 203, 1701-1711 (2006). (Pubitemid 44036276)
11. Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700 (2006). (Pubitemid 44036275)
12. von Herrath, M.G. & Harrison, L.C. Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3, 223-232 (2003). (Pubitemid 37323207)
13. Harrison, L.C. Vaccination against self to prevent autoimmune disease: the type 1 diabetes model. Immunol. Cell Biol. 86, 139-145 (2008). (Pubitemid 351301764)
14. + T-cell clones specifc for pancreatic islet autoantigens. J. Autoimmun. 36, 47-55 (2011).
15. Xia, M.Q., Tone, M., Packman, L., Hale, G. & Waldmann, H. Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur. J. Immunol. 21, 1677-1684 (1991).
16. Hale, G. Cd52 (Campath1). J. Biol. Regul. Homeost. Agents 15, 386-391 (2001).
17. + conventional T cells. Eur. J. Immunol. 37, 2378-2389 (2007). (Pubitemid 47423608)
18. Tone, M. et al. Structure and chromosomal location of mouse and human CD52 genes. Biochim. Biophys. Acta 1446, 334-340 (1999). (Pubitemid 29401905)
19. Chen, G.Y., Tang, J., Zheng, P. & Liu, Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323, 1722-1725 (2009).
20. Adorini, L., Gregori, S. & Harrison, L.C. Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med. 8, 31-38 (2002). (Pubitemid 34044676)
21. Augstein, P. et al. Beta-cell apoptosis in an accelerated model of autoimmune diabetes. Mol. Med. 4, 495-501 (1998). (Pubitemid 28473569)
22. + T regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
23. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. & Yamaguchi, T. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105-1111 (2009).
24. Collison, L.W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007). (Pubitemid 350190247)
25. Treumann, A., Lifely, M.R., Schneider, P. & Ferguson, M.A. Primary structure of CD52. J. Biol. Chem. 270, 6088-6099 (1995).
26. Mustelin, T. & Tasken, K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371, 15-27 (2003). (Pubitemid 36458075)
27. Varki, A. & Angata, T. Siglecs-the major subfamily of I-type lectins. Glycobiology 16, 1-27 (2006).
28. Crocker, P.R., Paulson, J.C. & Varki, A. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255-266 (2007). (Pubitemid 46480955)
29. Nguyen, D.H., Hutado-Ziola, N., Gagneux, P. & Varki, A. Loss of Siglec expression on T lymphocytes during human evolution. Proc. Natl. Acad. Sci. USA 103, 7765-7770 (2006).
30. MacDonald, H.R., Bron, C., Rousseaux, M., Horvath, C. & Cerottini, J.C. Production and characterization of monoclonal anti-Thy-1 antibodies that stimulate lymphokine production by cytolytic T cell clones. Eur. J. Immunol. 15, 495-501 (1985). (Pubitemid 15071582)
31. Korty, P.E., Brando, C. & Shevach, E.M. CD59 functions as a signal-transducing molecule for human T cell activation. J. Immunol. 146, 4092-4098 (1991).
32. Thompson, L.F., Ruedi, J.M., Glass, A., Low, M.G. & Lucas, A.H. Antibodies to 5′-nucleotidase (CD73), a glycosyl-phosphatidylinositol- anchored protein, cause human peripheral blood T cells to proliferate. J. Immunol. 143, 1815-1821 (1989). (Pubitemid 19241192)
33. Rowan, W.C., Hale, G., Tite, J.P. & Brett, S.J. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes. Int. Immunol. 7, 69-77 (1995).
34. + regulatory T cells. Clin. Immunol. 120, 247-259 (2006). (Pubitemid 44175899)
35. Kubota, H. et al. Identifcation and gene cloning of a new phosphatidylinositol-linked antigen expressed on mature lymphocytes. Down-regulation by lymphocyte activation. J. Immunol. 145, 3924-3931 (1990).
36. + T lymphocytes. Mol. Immunol. 42, 627-641 (2005). (Pubitemid 39655940)
37. Varki, A. Natural ligands for CD33-related Siglecs? Glycobiology 19, 810-812 (2009).
38. Clatworthy, M.R., Wallin, E.F. & Jayne, D.R. Anti-glomerular basement membrane disease after alemtuzumab. N. Engl. J. Med. 359, 768-769 (2008).
39. Coles, A.J. et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354, 1691-1695 (1999). (Pubitemid 29533060)
40. Coles, A.J. et al. Alemtuzumab vs. interferon β-1a in early multiple sclerosis. N. Engl. J. Med. 359, 1786-1801 (2008).
41. Cossburn, M. et al. Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology 77, 573-579 (2011).
42. Xia, M.-Q. et al. Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol anchored glycoprotein which is an exceptionally good target for complement lysis. Biochem. J. 293, 633-640 (1993). (Pubitemid 23244542)
43. Belov, L., Huang, P., Barber, N., Mulligan, S.P. & Christopherson, R.I. Identifcation of repertoires of surface antigens on leukemias using an antibody microarray. Proteomics 3, 2147-2154 (2003). (Pubitemid 37414081)
44. Armour, K.L., van de Winkel, J.G., Williamson, L.M. & Clark, M.R. Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies. Mol. Immunol. 40, 585-593 (2003). (Pubitemid 37329917)
45. Schmidt, T.G. & Skerra, A. The Strep-tag system for one-step purifcation and high-affnity detection or capturing of proteins. Nat. Protoc. 2, 1528-1535 (2007). (Pubitemid 46952331)
46. Herold, M.J., van den Brandt, J., Seibler, J. & Reichardt, H.M. Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl. Acad. Sci. USA 105, 18507-18512 (2008).